These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The quality of blood starts with its collection. Loos JA Vox Sang; 1994; 67 Suppl 3():77-9. PubMed ID: 7975516 [No Abstract] [Full Text] [Related]
3. [Developments in blood transfusion]. Krusius T; Porkka K Duodecim; 2004; 120(7):857-9. PubMed ID: 15154306 [No Abstract] [Full Text] [Related]
4. Transfusion medicine issues in the practice of anesthesiology. Robblee JA; Crosby E Transfus Med Rev; 1995 Jan; 9(1):60-78. PubMed ID: 7719039 [No Abstract] [Full Text] [Related]
5. [Various methods for good blood supply in Scandinavia]. Oldinger E Nord Med; 1996 Sep; 111(7):212-8. PubMed ID: 8927533 [No Abstract] [Full Text] [Related]
6. [Evolution of the practices of labile blood product distribution]. Tardivel R Transfus Clin Biol; 2005 Jun; 12(2):177-9. PubMed ID: 15894509 [No Abstract] [Full Text] [Related]
7. [Scandinavian recommendations for transfusion medicine]. Eklund J; Jørgensen J; Högman C; Jensson O; Kornstad L Nord Med; 1991; 106(11):299-300. PubMed ID: 1945807 [TBL] [Abstract][Full Text] [Related]
8. [State and perspectives of the French haemovigilance system. Presentation of the data collected over 9 years]. David B Transfus Clin Biol; 2003 Jun; 10(3):131-9. PubMed ID: 12798845 [No Abstract] [Full Text] [Related]
9. Quality assurance of blood components prepared in the blood transfusion center/blood bank. Vox Sang; 1994; 67(1):99-111. PubMed ID: 7975467 [No Abstract] [Full Text] [Related]
10. [Immunobiology--the neglected side of transfusion]. Flesland O; Solheim BG Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2493. PubMed ID: 11070981 [No Abstract] [Full Text] [Related]
11. ISO 9000 in transfusion medicine. Dickey WC; Pinover K Transfus Med Rev; 1998 Jul; 12(3):188-94. PubMed ID: 9673003 [No Abstract] [Full Text] [Related]
12. [European Union and blood transfusion]. Rouger P Transfus Clin Biol; 2003 Jun; 10(3):126-30. PubMed ID: 12798844 [TBL] [Abstract][Full Text] [Related]
13. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule. Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337 [TBL] [Abstract][Full Text] [Related]
14. Management of scarce resources in blood services in developing countries. Martínez MC Vox Sang; 2002 Aug; 83 Suppl 1():137-40. PubMed ID: 12617123 [No Abstract] [Full Text] [Related]
15. Blood program in Japan: current status. Ikeda H Transfus Apher Sci; 2002 Apr; 26(2):129-33. PubMed ID: 12121069 [No Abstract] [Full Text] [Related]
16. [Quality indicators and dashboards: the experience of a collection department]. Danic B; Bécel C; Beauplet A Transfus Clin Biol; 2000 Apr; 7(2):189-97. PubMed ID: 10812662 [TBL] [Abstract][Full Text] [Related]
17. Is there a limit to the normality of blood products? Hughes WG Hematol J; 2001; 2(3):212. PubMed ID: 11920249 [No Abstract] [Full Text] [Related]
18. International views on universal leucodepletion: the perspective in Germany. Seitz MD Transfus Sci; 1998 Dec; 19(4):359-60. PubMed ID: 10351155 [No Abstract] [Full Text] [Related]